Ivonescimab Phase 2 Shows Promise in First-Line mCRC at ASCO
30 May 2026 //
BUSINESSWIRE
GSK Withdraws Wellcovorin NDA
08 Apr 2026 //
FDA
Avyxa’s Vykoura Receives Approval in US
03 Feb 2026 //
FDA
30 May 2026 //
BUSINESSWIRE
08 Apr 2026 //
FDA
03 Feb 2026 //
FDA
Market Place
Sourcing Support